Berlin – International investors Farallon Capital, Red River West and Bertelsmann Investments, the venture arm of Bertelsmann, have increased the May 2021 Series B investment of $90 million in Berlin-based digital health company Ada Health GmbH ("Ada Health") by an additional $30 million. The round was initially led by Leaps by Bayer, the impact arm of Bayer AG, with additional investors Vitruvian Partners, Inteligo Bank, F4 and Mutschler Ventures. In addition, Schroders Capital has now joined Ada Health as a larger investor in a secondary.
The investment will help advance Ada’s popular health assessment technology, enabling the digital health pioneer to accelerate its path towards becoming the world's leading personalized operating system for health, as well as to further grow the company’s leading position in the United States. In addition to today’s announcement, Bayer and Ada Health are in discussions about entering into a longer-term strategic partnership to support the company’s healthcare businesses.
Ada Health has developed a powerful AI-based health assessment and care navigation platform that helps users to understand their symptoms, to identify and differentiate conditions with a high degree of medical accuracy, and to navigate safely to the right care, at the right time. Ada’s consumer app has become the world’s most popular and highest-rated symptom assessment app, with over 26 million assessments completed since its global launch.
Prof. Dr. Hans-Eric Rasmussen-Bonne has been associated with Ada Health since 2015 and, together with the venture capital team at the Berlin office, advised the shareholder BBPM GmbH and other shareholders in the financing round that has now been completed.
About Ada Health
Ada is a global health company founded by physicians, scientists and industry pioneers to create new opportunities for personal health. Its core system combines medical knowledge with smart technology to help everyone actively manage their health and enable healthcare professionals to deliver effective care, and the company partners with leading healthcare providers and organizations to make this vision a reality. The Ada platform has over 11 million users worldwide and has completed over 26 million assessments since its global launch in 2016. www.ada.com
Prof. Dr. Hans-Eric Rasmussen-Bonne, LL.M. (Corporate/Venture Capital, Berlin)
Andreas Michael, LL.M. (Corporate/Venture Capital, Berlin)